OFFICERS
CHAIR
Ed Eisenstein, Ph.D.
President
Institute for Bioscience and Biotechnology, University of Maryland
IMMEDIATE PAST CHAIR
Elizabeth Huntley
Head of Business Planning & Operations
AstraZeneca
SECRETARY
Samuel (Sandy) B. Sterrett Jr.
Partner
Rimon, PC
TREASURER
William (Bill) Snider
Co-Founder and Managing Partner
BroadOak Capitalx
DIRECTORS
Jennifer Bahrami
Global Head of Communications & Marketing
International Baccalaureate
Henry Bernstein
Senior Vice President
Scheer Partners
Lisa Carlton
Vice President of Global Regulatory Affairs
REGENXBIO Inc.
Steve Coats, Ph.D.
Chief Development Officer
ImmunOs Therapeutics
Kerron Duncan
Director, Architecture and Engineering & Chief Technology Office
Next Gen Technology
Chief Information Office
Northrop Grumman Corporation
Brian Rosen
Senior Vice President
Public Policy, Novavax
J.J. Finkelstein
President and Chief Executive Officer
RegeneRx Biopharmaceuticals, Inc.
Jeff Ford
Principal
CFR Engineering Consultants, Inc.
Alan S. Klein
Chief Development Officer
HealthWell Foundation
Lucy A. Rutishauser
Senior Vice President, Chief Financial Officer & Treasurer
Sinclair Broadcast Group
Kelly Lyn Warfield, Ph.D.
President, Research and Development
Sabin Vaccine Institute